Pharmaceutical Contract Manufacturing

Large pharmaceutical companies have been doing it for years and now smaller pharmaceutical companies are joining the trend.

It has been a long standing practice for large pharmaceutical companies to turn to contract manufacturing organizations (CMOs) to achieve efficiencies in cost and capacity, or to obtain a specific expertise not available in-house. While these factors are still valid, the most dynamic driver behind the use of CMOs in the pharmaceutical industry is rapidly becoming the unique, innovative, and state-of-the-art process and production technology on offer. More and more pharmaceutical companies are leaning towards outsourcing to concentrate on marketing their products, while saving time and headaches involved in manufacturing.

In the last decade or so there has been a complete globalisation in contract manufacturing with the involvement of companies from India. Worldwide revenue for contract manufacturing and research for the pharmaceutical industry was estimated at $100 billion in 2004 and is expected to grow in double digits to more than $160 billion in 2009.

Radico Remedies has been offering pharmaceutical contract manufacturing facilities to various pharma companies in India for several years and with the setting up of new state of art, fully computerised plant in the excise tax free area of Barotiwala, we expect to serve our customers better and at a lower cost.

 To know more about us, please fill up our enquiry form.

Last updated: 2 June, 2006